Pro 2012-016 (Jianfeng Group's Announcement on Convening Shareholders' General Meeting)
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Lin 2012-016
Zhejiang Jianfeng Group Co., Ltd.
Notice on Convening the First Extraordinary General Meeting in 2012
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
Important Content Tips
● Meeting Time: September 12, 2012 (Wednesday) 9:00 a.m.
● Meeting Pre-registration Time: September 11, 2012
● Meeting Place: Jianfeng Building
, 88 Wujiang East Road, Jinhua City, Zhejiang Province ● Meeting Method: Site Method
● Whether to Provide Online Voting: no
1. Meeting Basic Information
Zhejiang Jianfeng Group Co., Ltd. (hereinafter referred to as "the Company") The 6th meeting of the 8th Board of Directors was held in the Company on 2012 8 24 . The meeting decided: at 9:00 a.m. on September 12, 2012 (Wednesday), at Jianfeng Building, 88 Wujiang East Road, Jinhua City, Zhejiang Province, the first extraordinary shareholders' meeting of the company in 2012 was held on the spot.
2. meeting to consider matters1, to consider the amendment of the company's articles of association.
2. Review the company's "Shareholder Return Plan for the Next Three Years (2012-2014).
3. Meeting Attendees
1. All shareholders of the company and their authorized clients registered with China Securities Central Depository and Clearing Corporation Shanghai Branch after the end of trading on September 7, 2012 (Friday) All clients can attend.
2. Directors, supervisors and senior management of the Company.
4. registration method
, legal person shareholder holding unit certificate, legal representative power of attorney and attendee ID card registration; Public shareholders register with their shareholder account card and their ID card. Shareholders can pre-register by letter or fax.
2. Pre-registration time: September 11, 2012.
. Place of registration: Room 306, Jianfeng Building, 88 Wujiang East Road, Jinhua City, Zhejiang Province.
Other matters 5.
1
, the duration of the meeting is expected to be half a day, and the transportation and accommodation expenses of the participants shall be borne by themselves.
, contact address: Room 306, Jianfeng Building, 88 Wujiang East Road, Jinhua City, Zhejiang Province .
3, Postal Code: 321000
4, Tel: 0579-82324699
5, Contact Fax: 0579-82324699
hereby announceAugust 28, 2012
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
with
Power of Attorney:
I hereby entrust Mr. (Ms.) to attend the first extraordinary general meeting of shareholders of Zhejiang Jianfeng Group Co., Ltd. in 2012 on my behalf, and vote on each proposal in accordance with the instructions of the client. If the client has no instructions, the trustee will vote by himself.Principal Signature:
Principal Shareholder Account Number: Principal Identity Card Number:
Principal Shareholding Number:
Trustee Signature: Trustee Identity Card Number:
Validity Period:
Date of Entrustment
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31